Alzheimer's disease
C2N Building Case for Alzheimer's Dx as Aducanumab Approval Promises to Impact Testing Space
Premium
FDA's approval of the Biogen anti-amyloid Alzheimer's drug could drive demand for new tests for the disease, including potentially C2N's blood-based assay.
Alzheon, Czech Institute of Organic Chemistry and Biochemistry Partner on Alzheimer's Test
The partners will develop an assay to measure neurotoxic beta amyloid oligomers in human cerebrospinal fluid.
Norwegian Startup Pre Diagnostics Developing Monocyte Test for Presymptomatic Alzheimer's Disease
Premium
The firm said its test detects biomarkers inside monocyte blood cells that reflect the reduced clearance of amyloid-beta plaque that leads to Alzheimer's disease.
Tataa Biocenter Takes Majority Stake in Swedish Genetic Testing Firm Life Genomics
Life Genomics markets a noninvasive prenatal test for chromosomal abnormalities, a genetic disease carrier test, and an Alzheimer's disease risk test.
Helix Obtains FDA Authorization for Exome Sequencing Platform, Alzheimer's Disease Risk Test
The Helix Laboratory Platform is the first whole-exome sequencing platform to receive do novo authorization by the agency and paves the way for others.